Risk Breakdown
Financial Exposure
Governance
Double Materiality
Supply Chain
Material Risks
ESG Targets & Commitments
| Topic | Target / Metric | Status |
|---|---|---|
| Human Rights in Supply Chain | HR clauses in all contracts | Commitment |
AI Risk Summary
**RPG Life Sciences Limited – Financial Risk Summary** RPG Life Sciences faces a critical compliance exposure of ₹1–4 crore annually under SEBI BRSR Core Expansion mandates, with a maximum compliance risk score of 10.0/10 posing delisting or enforcement action risk if disclosure and environmental reporting obligations are not met. The company's EPR (Extended Producer Responsibility) exposure of 6.5/10 remains unresolved—unknown applicability across pharmaceutical product categories creates contingent liability risk, as mandatory EPR compliance under Plastic Waste Management Rules 2021 could trigger significant operational costs. Notably, the absence of reported Scope 1 and Scope 2 emissions data (despite manufacturing operations) suggests measurement gaps rather than zero impact; this disclosure failure directly violates BRSR P6 requirements and increases regulatory scrutiny likelihood. With medium ESG risk (5.5/10) driven primarily by compliance gaps, the company must immediately quantify emissions, clarify EPR obligations, and establish robust environmental management reporting to mitigate ₹1–4 crore compliance costs and regulatory penalties.
Source: RPG Life Sciences Limited BRSR Filing, FY -. Derived from the company's own public disclosures. Not investment advice or a regulatory determination.